Medtronic Accounts payable and other current liabilities decreased by 263.4% to -$598.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.0%, from -$604.00M to -$598.00M. Over 4 years (FY 2021 to FY 2025), Accounts payable and other current liabilities shows a downward trend with a -20.8% CAGR.
An increase suggests the company is effectively utilizing supplier credit to preserve cash, while a decrease indicates faster payment cycles.
Reflects the net change in obligations to suppliers and other accrued expenses that have been incurred but not yet paid....
A standard working capital metric used to evaluate cash management strategies across all sectors.
other_increase_decrease_in_accounts_payable_and_accrued__ecb401| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | -$416.00M | $402.00M | $20.00M | $207.00M | -$147.00M | -$552.00M | $862.00M | $533.00M | -$673.00M | -$34.00M | $454.00M | $644.00M | -$604.00M | -$176.00M | $623.00M | $366.00M | -$598.00M |
| QoQ Change | — | <-999% | +196.6% | -95.0% | +935.0% | -171.0% | -275.5% | +256.2% | -38.2% | -226.3% | +94.9% | >999% | +41.9% | -193.8% | +70.9% | +454.0% | -41.3% | -263.4% |
| YoY Change | — | — | — | — | >999% | +64.7% | -237.3% | >999% | +157.5% | -357.8% | +93.8% | -47.3% | +20.8% | +10.3% | -417.6% | +37.2% | -43.2% | +1.0% |